ChristopherMarcMaiselMD

PubMed

• 6 citations
  Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
  Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Maria-Victoria Mateos, Michele Cavo, Christopher Maisel, Adrian Alegre, Albert Oriol, Anasta...> ;British Journal of Haematology. 2021 Oct 21
• 79 citations
  Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
  Paul G. Richardson, Albert Oriol, Alessandra Larocca, Joan Bladé, Michele Cavo, Paula Rodriguez-Otero, Xavier Leleu, Omar Nadeem, John W. Hiemenz, Hani Hassoun, Cyrill...> ;Journal of Clinical Oncology. 2021 Mar 1
• Simultaneous presentation of two distinct plasma cell neoplasms
  David M. Metter, Christopher Maisel, John R. Krause> ;Proceedings. 2018 Oct 19
• 1 citations
  Haematological complete remission by ponatinib and bortezomib in a patient with relapsed, Ph+ pre-B acute lymphoblastic leukaemia
  Sara D. Robinson, Yair Levy, Christopher Maisel, Alex W. Tong> ;BMJ Case Reports. 2014 Apr 12
• 26 citations
  Report of a Phase II Study of Clofarabine and Cytarabine in De Novo and Relapsed and Refractory AML Patients and in Selected Elderly Patients at High Risk for Anthracy...
  Edward Agura, Barry Cooper, Houston Holmes, Estil Vance, Robert Brian Berryman, Christopher Maisel, Sandy Li, Giovanna Saracino, Mirjana Tadic-Ovcina, Joseph Fay> ;The Oncologist. 2011 Feb 1
• Join now to see all

Abstracts/Posters

• The Burden of Relapsed/Refractory Multiple Myeloma: An Indirect Comparison of Health-Related Quality of Life Burden across Different Types of Advanced Cancers at Basel...
  Christopher Maisel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical Activity of Melflufen in Patients with Triple-Class Refractory Multiple Myeloma and Poor-Risk Features in an Updated Analysis of HORIZON (OP-106), a Phase 2 S...
  Christopher Maisel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019